Alfa Aesar Acquires Life Science Reagent Company

Owned by Johnson Matthey, Alfa Aesar had 2012 sales of £79 million ($125 million = £0.63 = $1). Based in Stoughton, Massachusetts, BTI expands Alfa Aesar’s life science product lines.

Heysham, UK 9/16/13—Research chemicals provider Alfa Aesar has bought Biomedical Technologies (BTI). BTI product lines include specialty proteins, cell culture additives and immunoassay tools. “The acquisition of BTI brings protein research and characterization, all types of profiling tools and certain separation technologies and provides opportunities for Alfa Aesar to leverage BTI’s manufacturing capabilities to enhance its overall product offering,” said Julie Butterfield, general manager of Alfa Aesar.

< | >